These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6368 related articles for article (PubMed ID: 3257967)

  • 141. Melanoma-associated antigens recognized by cytotoxic T lymphocytes.
    Kirkin AF; Dzhandzhugazyan K; Zeuthen J
    APMIS; 1998 Jul; 106(7):665-79. PubMed ID: 9740504
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Cancer mortality among Iowa farmers: recent results, time trends, and lifestyle factors (United States).
    Cerhan JR; Cantor KP; Williamson K; Lynch CF; Torner JC; Burmeister LF
    Cancer Causes Control; 1998 May; 9(3):311-9. PubMed ID: 9684711
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study.
    Mordoh J; Kairiyama C; Bover L; Solarolo E
    Medicina (B Aires); 1997; 57(4):421-7. PubMed ID: 9674264
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Post-translational regulation of surface integrin expression in tumor cells by 12(S)-HETE.
    Timar J; Bazaz R; Tang DG; Kimler V; Taylor JD; Honn KV
    Adv Exp Med Biol; 1997; 400B():757-63. PubMed ID: 9547627
    [No Abstract]   [Full Text] [Related]  

  • 145. Immunotherapy of metastases with lymphocytes treated with exogenous RNA in mice bearing B16 melanoma.
    Watanabe MA; Almeida DO; Serrano SV; Sales VS; Soares FA; de Lucca FL
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):393-8. PubMed ID: 9193794
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Inhibition of motility and invasion of B16 melanoma by the overexpression of cystatin C.
    Sexton PS; Cox JL
    Melanoma Res; 1997 Apr; 7(2):97-101. PubMed ID: 9167174
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Infiltration and lysis of tumour cell aggregates by adherent interleukin-2-activated natural killer cells is distinct from specific cytolysis.
    Johansson BR; Unger ML; Albertsson P; Casselbrant A; Nannmark U; Hokland M
    Nat Immun; 1996-1997; 15(2-3):87-97. PubMed ID: 9162267
    [TBL] [Abstract][Full Text] [Related]  

  • 148. PET in oncology: will it replace the other modalities?
    Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
    Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
    [TBL] [Abstract][Full Text] [Related]  

  • 149. Histidine decarboxylase and intracellular histamine in melanoma cells and in a T cell line.
    Falus A; László V; Radvány Z; Hegyesi H; Kiss B; Bencsáth M; Darvas Z
    Inflamm Res; 1997 Mar; 46 Suppl 1():S51-2. PubMed ID: 9098761
    [No Abstract]   [Full Text] [Related]  

  • 150. Antitumor agents. 168. Dysoxylum cumingianum. IV. The structures of cumingianosides G-O, new triterpene glucosides with a 14,18-cycloapotirucallane-type skeleton from Dysoxylum cumingianum, and their cytotoxicity against human cancer cell lines.
    Fujioka T; Sakurai A; Mihashi K; Kashiwada Y; Chen IS; Lee KH
    Chem Pharm Bull (Tokyo); 1997 Jan; 45(1):68-74. PubMed ID: 9023969
    [TBL] [Abstract][Full Text] [Related]  

  • 151. Tissue distribution of a melanoma-associated antigen immunogenic in patients with melanoma as analyzed by polyclonal antibodies to recombinant peptide antigen.
    Kako S; Hayashibe K; Ichihashi M
    J Dermatol; 1996 Apr; 23(4):230-7. PubMed ID: 8935336
    [TBL] [Abstract][Full Text] [Related]  

  • 152. The influence of the oncogenes NRAS and MYC on the radiation sensitivity of cells of a human melanoma cell line.
    Pomp J; Ouwerkerk IJ; Hermans J; Wondergem J; Cornelisse CJ; Leer JW; Schrier PI
    Radiat Res; 1996 Oct; 146(4):374-81. PubMed ID: 8927709
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Congenital melanoma: a case suggesting rhabdomyogenic differentiation.
    Koyama T; Murakami M; Nishihara O; Masuda T
    Pediatr Dermatol; 1996; 13(5):389-93. PubMed ID: 8893239
    [TBL] [Abstract][Full Text] [Related]  

  • 154. Posterior uveal melanoma. The Swedish perspective.
    Seregard S
    Acta Ophthalmol Scand; 1996 Aug; 74(4):315-29. PubMed ID: 8883543
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Reticulohistiocytoma involving the skin, subcutaneous tissue and a regional lymph node.
    Suwabe H; Tsutsumi Y
    Pathol Int; 1996 Jul; 46(7):531-7. PubMed ID: 8870011
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy.
    Olencki T; Finke J; Tubbs R; Tuason L; Greene T; McLain D; Swanson SJ; Herzog P; Stanley J; Edinger M; Budd GT; Bukowski RM
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):69-80. PubMed ID: 8859726
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Acquired homozygosity (isodisomy) of chromosome 3 during clonal evolution of a uveal melanoma: association with morphologic heterogeneity.
    White VA; McNeil BK; Thiberville L; Horsman DE
    Genes Chromosomes Cancer; 1996 Feb; 15(2):138-43. PubMed ID: 8834179
    [TBL] [Abstract][Full Text] [Related]  

  • 158. Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a nonantisense mechanism.
    Jansen B; Wadl H; Inoue SA; Trülzsch B; Selzer E; Duchêne M; Eichler HG; Wolff K; Pehamberger H
    Antisense Res Dev; 1995; 5(4):271-7. PubMed ID: 8746776
    [TBL] [Abstract][Full Text] [Related]  

  • 159. Introduction: human pathology within the broad scope of comparative pathology.
    Kaiser HE
    In Vivo; 1996; 10(2):125-30. PubMed ID: 8744790
    [TBL] [Abstract][Full Text] [Related]  

  • 160. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo.
    Nierodzik ML; Klepfish A; Karpatkin S
    Thromb Haemost; 1995 Jul; 74(1):282-90. PubMed ID: 8578473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 319.